PharmaSources/CaicaiAugust 06, 2020
Tag: clinical , National Health Commission of China , oncology drugs
(July.27th-31th)
25. The National Health Commission of China issued the Administrative Measures for the Clinical Use of Oncology Drugs (Draft for Comment) on July 29 in order to strengthen the administration of the clinical use of medical institutions’ oncology drugs, improve the levels of rational clinical use of oncology drugs, standardize the behaviors of clinically using oncology drugs, and guarantee the medical quality and safety.
Read More:
Pharmaceutical News of the Week | CPhI.CN - Performance
Caicai, a Master of Pharmacy from Shanghai Jiaotong University, used to work in the Institute of Science and Technical Information. Currently as a practitioner in the drug surveillance system, she is good at interpreting industry regulations, pharmaceutical research developments, etc.
-----------------------------------------------------------------------
Editor's Note:
To become a freelance writer of PharmaSources.com,
welcome to send your CV and sample works to us,
Email: Julia.Zhang@imsinoexpo.com.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: